Inventor
Christopher John O'Donnell
Inventor
Mystic, CT, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07CAcyclic or carbocyclic compounds3%
C07HSugars3%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers1%
B65HHandling thin or filamentary material, e.g. sheets, webs, cables1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
11,021,339Elastic band dispenser202110,391,182Bifunctional cytotoxic agents201910,086,085Bifunctional cytotoxic agents20189,764,040'Spliceostatin analogs and methods for their preparation'20179,751,877'Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders'20179,504,669'Spliceostatin analogs and methods for their preparation'20169,249,186'Cytotoxic peptides and antibody drug conjugates thereof'20169,193,726'Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders'20159,169,264'Spliceostatin analogs and methods for their preparation'20159,138,486'Cytotoxic peptides and antibody drug conjugates thereof'20159,067,934'Bicyclic pyridinones'20158,916,564'Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders'20148,828,401'Cytotoxic peptides and antibody drug conjugates thereof'20148,697,673'Bicyclic pyridinones'20148,686,043'Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof'20148,278,457'Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof'20127,456,177'Heteroaryl fused azapolycyclic compounds'20087,442,694'Diazabicyclic compounds useful in the treatment of CNS and other disorders'20087,439,236'Pharmaceutical composition for the treatment of CNS and other disorders'20086,881,734'Pharmaceutical composition for the treatment of CNS and other disorders'20056,809,094'Pharmaceutical composition for the treatment of CNS and other disorders'20046,673,811'1H-pyrrolo 3,2-b pyridine-3-carboxylic acid amines as GABAA receptor ligands'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2019Patents assigned to PFIZER (21)· patent assignee history
2004–2019Based in Mystic, CT, US· patent location history
2012–2014Patents assigned to O'DONNELL CHRISTOPHER JOHN (3)· patent assignee history
2012–2014Patents assigned to GALLASCHUN RANDALL JAMES (2)· patent assignee history
2012–2014Patents assigned to SCHWARZ JACOB BRADLEY (2)· patent assignee history
2014Patents assigned to AM ENDE CHRISTOPHER WILLIAM (1)· patent assignee history
2021Based in Worthington, MN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PFIZER | 21 | 2004–2019 |
| O'DONNELL CHRISTOPHER JOHNself | 3 | 2012–2014 |
| GALLASCHUN RANDALL JAMES | 2 | 2012–2014 |
| SCHWARZ JACOB BRADLEY | 2 | 2012–2014 |
| AM ENDE CHRISTOPHER WILLIAM | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mystic, CT, US | 21 | 2004–2019 |
| Worthington, Minnesota, US | 1 | 2021 |